Future Labs Capital Announces Additional Investment in AssayQuant Technologies, Inc.
Accesswire
*Investment to support more effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious health..
*Investment to support more effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious health..
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today..
‘Barbenheimer’ Opening Weekend , Brings In $235.5 Million Combined.
‘Barbenheimer’ Opening Weekend , Brings In $235.5..